Skip to main content
$40.23 $1.67 (4.3%)

04:00 PM EDT on 09/28/22

Sage Therapeutics, Inc. (NASDAQ:SAGE)

CAPS Rating: 1 out of 5

Current Price $40.23 Mkt Cap $2.3B
Open $39.23 P/E Ratio 0.00
Prev. Close $40.23 Div. (Yield) $0.00 (0.0%)
Daily Range $39.23 - $40.77 Volume 514,859
52-Wk Range $27.36 - $47.75 Avg. Daily Vol. 468,117

Caps

How do you think NASDAQ:SAGE will perform against the market?

Add Stock to CAPS Watchlist

All Players

42 Outperform
8 Underperform
 

All-Star Players

11 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SAGE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

GNUBEE (< 20)
Submitted November 10, 2014

fist pick in a few years, following Porte to get my feet wet...

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:SAGE Summary

Fools bullish on NASDAQ:SAGE are also bullish on:

Fools bearish on NASDAQ:SAGE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SAGE.

Recs

0
Member Avatar XMFRendezvous (97.67) Submitted: 2/9/2018 3:08:16 AM : Outperform Start Price: $159.02 NASDAQ:SAGE Score: -116.77

Sage Therapeutics has had an incredible few months as the FDA has fast tracked some of their treatments. Sage business seems to be catching some headwinds and they are looking to offer more stock to continue to fuel their business. Many of their drugs have to do with mental disorders such a depression, and where I do question the merits of drugs for mental illness I acknowledge the science behind it and unfortunately I do think that mental health will only continue to be more of an issue in the future.

I always have trouble writing about Biotechs because I really don't know what I am taking about but, many biotech analysts are high on this stock. Sage looks to be like one of the top programmers.

Recs

0
Member Avatar TMFGBudwell (< 20) Submitted: 12/7/2017 5:33:35 PM : Outperform Start Price: $158.97 NASDAQ:SAGE Score: -114.51

Multiple product candidates in development.

Recs

0
Member Avatar texasredraider94 (55.23) Submitted: 7/14/2016 7:22:56 AM : Outperform Start Price: $43.43 NASDAQ:SAGE Score: -78.58

Only drug to successfully treat a widespread problem among new mothers

Leaderboard

Find the members with the highest scoring picks in SAGE.

Score Leader

BeatdaMarket

BeatdaMarket (52.23) Score: +160.45

The Score Leader is the player with the highest score across all their picks in SAGE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WildShaman 65.87 7/9/2018 Underperform 5Y $160.36 -74.91% +33.98% +108.89 0 Comment
zzlangerhans 99.74 9/11/2017 Underperform 1Y $88.32 -54.45% +49.38% +103.82 0 Comment
FunesDMemorious 28.26 3/23/2016 Underperform 5Y $28.09 +43.22% +81.71% +38.50 0 Comment
Magic100value 74.47 2/18/2022 Outperform 5Y $34.37 +17.07% -14.84% +31.91 0 Comment
DyingClub < 20 8/3/2020 Underperform 5Y $46.09 -12.71% +12.85% +25.56 0 Comment
chammond55 95.55 12/8/2021 Outperform 5Y $40.40 -0.41% -20.78% +20.37 0 Comment
drugtrader 79.82 4/16/2020 Outperform 5Y $26.90 +49.55% +32.73% +16.82 0 Comment
Atn1027 26.07 1/13/2022 Outperform 1Y $42.84 -6.09% -21.53% +15.44 0 Comment
NorteClub 82.66 6/11/2020 Underperform 5Y $36.38 +10.58% +19.00% +8.42 0 Comment
PandaTears < 20 7/26/2021 Outperform 5Y $44.99 -10.58% -15.66% +5.08 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SAGE.